Technological breakthrough will allow world to return to pre-COVID “normal” in near future
West Palm Beach, FL in 26-01-2021, Advanced Medical Solutions International (AMSI) announced at an international press conference the details of The COVID Hunter, the world’s first touchless viral detector specially designed to immediately identify the presence of the SARS-CoV-2 virus.
The COVID Hunter is a non-invasive, touchless, immediate, and portable detector of the virus SARS-CoV-2 which causes the disease COVID-19, demonstrating >99% specificity and sensitivity within 0-2 meters (6.5 feet) on surfaces, through glass or transparent material, and inside the human body.
Nobel Prize-winning molecular geneticist, Professor Mario Capecchi, serves as an advisor to AMSI on this and the company’s other breakthrough technologies – including a cure for allergic airway disease and chronic obstructive pulmonary disease (COPD) that is currently in the preliminary phase of FDA approval. AMSI technology builds upon research performed by Professor Maria Grant at the University of Florida and the University of Alabama at Birmingham and the work of Dr. Adeeb Al-Zoubi at Stem Cells Arabia in Jordan, the sister company of AMSI.
AMSI is working with Biologics Consulting Group, Inc. to handle our FDA Emergency Use Authorization (EUA) submission for The COVID Hunter.
“The handheld COVID Hunter will revolutionize the way SARS-CoV-2 (including mutated strains) is detected, slowing the spread of the deadly virus, saving lives, and returning life to ‘normal’ in the near future,” explains Donald Redman, Co-founder and Chief Executive Officer of AMSI.
The distribution of The COVID Hunter would allow rooms, restaurants, venues, vehicles, hospitals, hotels, schools, offices, and others to be scanned for SARS-CoV-2. Surfaces with the virus will be cleaned and retested to ensure the disinfectant was successful. Once areas are clean, persons and objects entering the area would be scanned to screen for the virus.
COVID-free “bubbles” would make social distancing, masks, and occupancy restrictions obsolete, allowing for the rapid resumption of common activities.
“We utilized specific spectra of electromagnetic waves to identify the unique ‘thumbprint’ of the virus,” explains Dr. Adeeb Al-Zoubi, Co-Founder and Chief Scientific Officer of AMSI, “As new mutations are found, The COVID Hunter is capable of being ‘updated’ to detect new strains of the virus, making it a critical weapon to defeat the spread of the pandemic.”
Frontline healthcare workers worldwide are the leaders of the fight against the pandemic and must have access to the supply of this product at the outset. The COVID Hunter technology will also go to the heads of governments worldwide for immediate positioning in their respective battles against the pandemic.
To meet the demand of the international market, the COVID Hunter will be manufactured in multiple regions including Central America, Southeast Asia, and the Middle East.
About AMSI
Advanced Medical Solutions International is a research and development firm based in West Palm Beach, Florida with almost 7 years in business. Through strong international partnerships, AMSI produces cutting-edge medical solutions to humanity’s greatest public health challenges including SARS-CoV-2, COPD, IVF, and diabetes.
TECHNICAL ASPECTS OF THE COVID HUNTER
- Non-invasive, non-touch, immediate, and portable detection of SARS-CoV-2
- Immediate detection of SARS-CoV-2 from 0-2 meters away with >99% specificity and sensitivity
- Detection through glass or transparent material
- Immediate detection of 2 internal and external components of SARS-CoV-2 (such as RNA or spike protein) in a specific and sensitive manner
- Immediate detection of SARS-CoV-2 in any human sample, including nasal swabs, oral swabs, sputum, saliva, bronchoalveolar lavage (lung aspirate)
- Immediate detection of SARS-CoV-2 inside human body (identification of people infected with SARS-CoV-2 (“carriers”)) in a non-invasive manner
- Immediate detection of SARS-CoV-2 in air coughed or sneezed or blown out of mouth or nose of infected people into a transparent container (identification of people infected with SARS-CoV-2 AND who are infectious (transmitters of infection))
- Immediate detection of SARs-CoV-2 in different body organs (throat, lung, sinus)
- Immediate detection of SARS-CoV-2 on the outside of human body (skin and clothes)
- Immediate detection of SARS-CoV-2 on contaminated objects (such as door handles, mobile phones, high-touch surfaces, packages, etc.)
- Verification of RT-PCR results of COVID19 (SARS-CoV-2) infection to eliminate false readings
- 1-piece unit with battery charging station
- Enabled to download new mutation strains to detect the evolving virus
- SARS-CoV-2 detection indicator to convey amount of virus present
- Audio/visual display alert system for positive identification of SARS-CoV-2
- 12V rechargeable batteries
- 10 available memory “slots” for SARS-CoV-2-programs
- Device pre-programmed with 3 “targets”
- SARS-CoV-2 RNA
- Useful to detect internal parts of the virus (such as the genetic material of the virus)
- SARS-CoV-2 Spike-protein
- Useful to detect fully-assembled viral particles
- SARS-CoV-2 Combined: Spike-protein and RNA
- Detects different parts of the virus
- 7 available memory slots for future mutation
- SARS-CoV-2 RNA
- The device can be used to distinguish SARS-CoV-2 from other viruses such as influenza, norovirus, etc.
- Device pre-programmed with 3 “targets”
